MAPT and Alzheimer disease: In order to examine the consequences of the LC degeneration in AD in general, either knockout mouse models, such as DBH(−/−), Ear2(−/−), or selective neurotoxins, such as DSP4, have been used in combination with amyloid or tau transgenic mice.